Force A has a magnitude F and acts for the time Δt, force B has a magnitude 2F and acts for the time Δt/3, force C has a magnitude 5F and acts for the time Δt/10, and force D has a magnitude 10F and acts for the time Δt/100. Rank these forces in order of decreasing impulse.

Follow these directions and answer the questions. 1. set up the ripple tank as in previous investigations. 2. bend the rubber tube to form a "concave mirror" and place in the ripple tank. the water level must be below the top of the hose. 3. generate a few straight pulses with the dowel and observe the reflected waves. do the waves focus (come together) upon reflection? can you locate the place where the waves meet? 4. touch the water surface where the waves converged. what happens to the reflected wave? 5. move your finger twice that distance from the hose (2f = c of c, center of the curvature) and touch the water again. does the image (the reflected wave) appear in the same location (c of c)? you may have to experiment before you find the exact location. sometimes it is hard to visualize with the ripple tank because the waves move so quickly. likewise, it is impossible to "see" light waves because they have such small wavelengths and move at the speed of light. however, both are examples of transverse waves and behave in the same way when a parallel wave fronts hit a curved surface.

How are series and parallel circuits simililar? both have multiple paths for electrons to travel. both require resistors in their circuits. both require a switch to complete the circuit. both have at least one path for electrons to travel.

Asubject in a clinical research trial experiences a serious, unanticipated adverse drug experience. how should the investigator proceed, with respect to the irb, after the discovery of the adverse event occurrence? a. do not report the adverse drug experience to the irb since it is a common adverse experience.b. report the adverse drug experience to the irb only if there are several other occurrences.c. report the adverse drug experience as part of the continuing review report.d. report the adverse drug experience in a timely manner, in keeping with the irb's policies and procedures, using the forms or the mechanism provided by the irb.